Abenaa M. Brewster, M.D., M.H.S.

Peer-Reviewed Articles

1. Wilson RL, Giobbie-Hurder A, Bender CM, Brewster AM, Crane TE, Hopkins JO, Masters GA, Pierce LJ, Ligibel JA, Dieli-Conwright CM. Barriers to the Adoption of Healthy Lifestyle Behaviors in Patients With Cancer: Results of a National Survey. JCO Oncol Pract:OP2501029, 2026. e-Pub 2026. PMID: 41701954.
2. Li JL, Zhang H, Wang X, Jia G, McClellan JC, Guo W, Sun Y, Fiorica PN, Ambs S, Barnard ME, Chen Y, Garcia-Closas M, Gu J, Hu JJ, John EM, Nathanson KL, Nemesure B, Pal T, Shu XO, Press MF, Sanderson M, Sandler DP, Troester MA, Yao S, Long J, Ahearn TU, Brewster AM, Falusi A, Kraft P, Hennis AJM, Makumbi T, Mapoko BSE, O'Brien KM, Ojengbede O, Olshan AF, Reid S, Zirpoli G, Cai Q, Butler EN, Huang M, Obafunwa J, Weinberg CR, Ambrosone C, Ping J, Tao R, Li B, Guo X, Gao G, Conti DV, Chatterjee N, Palmer JR, Olopade OI, Zheng W, Haiman CA, Huo D. Improved polygenic risk prediction models for breast cancer subtypes in women of African ancestry. Nat Genet, 2026. e-Pub 2026. PMID: 41629673.
3. Lee CY, Laffoon K, Mama SK, Liao Y, Whisenant M, Brewster A, Mendoza T, Mitchell SJ, Tracy PV, Garza GM, Basen-Engquist KM. Outcomes for breast cancer survivors with metastatic disease in a physical activity program for medically underserved cancer survivors. J Cancer Surviv 19(6):1861-1870, 2025. e-Pub 2025. PMID: 38801567.
4. Jia G, Ping J, Tao R, Long J, Liu L, Xu S, Munro HM, Ambs S, Barnard ME, Chen Y, Choi JY, Gao YT, Garcia-Closas M, Gu J, Hu JJ, Iwasaki M, John EM, Kweon SS, Matsuda K, Matsuo K, Nathanson K, Nemesure B, Olopade OI, Pal T, Park SK, Park B, Press MF, Sanderson M, Sandler DP, Yao S, Zheng Y, Adejumo PO, Ahearn T, Brewster AM, Hennis AJM, Ito H, Kubo M, Lee ES, Low SK, Makumbi T, Ndom P, Noh DY, O'Brien KM, Olshan AF, Oluwasanu MM, Park MH, Reid S, Yamaji T, Zirpoli G, Butler EN, Huang M, Ntekim A, Weinberg CR, Li B, Huo D, Kang D, Ambrosone C, Troester MA, Haiman CA, Shu XO, Palmer JR, Guo X, Zheng W. Integrating multi-ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci. Int J Cancer 157(10):2071-2080, 2025. e-Pub 2025. PMID: 40658085.
5. Jia G, Chen Z, Ping J, Cai Q, Tao R, Li C, Bauer JA, Xie Y, Ambs S, Barnard ME, Chen Y, Choi JY, Gao YT, Garcia-Closas M, Gu J, Hu JJ, Iwasaki M, John EM, Kweon SS, Li CI, Matsuda K, Matsuo K, Nathanson KL, Nemesure B, Olopade OI, Pal T, Park SK, Park B, Press MF, Sanderson M, Sandler DP, Shen CY, Troester MA, Yao S, Zheng Y, Ahearn T, Brewster AM, Falusi A, Hennis AJM, Ito H, Kubo M, Lee ES, Makumbi T, Ndom P, Noh DY, O'Brien KM, Ojengbede O, Olshan AF, Park MH, Reid S, Yamaji T, Zirpoli G, Butler EN, Huang M, Low SK, Obafunwa J, Weinberg CR, Zhang H, Zhao H, Cote ML, Ambrosone CB, Huo D, Li B, Kang D, Palmer JR, Shu XO, Haiman CA, Guo X, Long J, Zheng W. Refining breast cancer genetic risk and biology through multi-ancestry fine-mapping analyses of 192 risk regions. Nat Genet 57(1):80-87, 2025. e-Pub 2025. PMID: 39753771.
6. Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial. Int J Radiat Oncol Biol Phys 121(4):885-893, 2024. e-Pub 2024. PMID: 39486645.
7. Yam C, Patel M, Hill HA, Sun R, Bassett RL, Kong E, Damodaran S, Koenig KB, Abouharb S, Saleem S, Bisen AK, Murthy RK, Ramirez DL, Rauch GM, Adrada BE, Candelaria RP, Wang X, Mittendorf EA, Thompson AM, White JB, Ravenberg EE, Clayborn AR, Ding QQ, Booser DJ, Oke O, Brewster AM, Hortobagyi GN, Ibrahim NK, Litton JK, Valero V, Arun BK, Tripathy D, Chang JT, Chen K, Korkut A, Moulder SL, Huo L, Lim B, Ueno NT. Targeting the EGFR pathway in chemotherapy-resistant triple-negative breast cancer - a phase II study. Cancer Res Commun 4(10):2823-2834, 2024. e-Pub 2024. PMID: 39356138.
8. Ping J, Jia G, Cai Q, Guo X, Tao R, Ambrosone C, Huo D, Ambs S, Barnard ME, Chen Y, Garcia-Closas M, Gu J, Hu JJ, John EM, Li CI, Nathanson K, Nemesure B, Olopade OI, Pal T, Press MF, Sanderson M, Sandler DP, Yoshimatsu T, Adejumo PO, Ahearn T, Brewster AM, Hennis AJM, Makumbi T, Ndom P, O'Brien KM, Olshan AF, Oluwasanu MM, Reid S, Yao S, Butler EN, Huang M, Ntekim A, Li B, Troester MA, Palmer JR, Haiman CA, Long J, Zheng W. Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes. Nat Commun 15(1):3718, 2024. e-Pub 2024. PMID: 38697998.
9. Jia G, Ping J, Guo X, Yang Y, Tao R, Li B, Ambs S, Barnard ME, Chen Y, Garcia-Closas M, Gu J, Hu JJ, Huo D, John EM, Li CI, Li JL, Nathanson KL, Nemesure B, Olopade OI, Pal T, Press MF, Sanderson M, Sandler DP, Shu XO, Troester MA, Yao S, Adejumo PO, Ahearn T, Brewster AM, Hennis AJM, Makumbi T, Ndom P, O'Brien KM, Olshan AF, Oluwasanu MM, Reid S, Butler EN, Huang M, Ntekim A, Qian H, Zhang H, Ambrosone CB, Cai Q, Long J, Palmer JR, Haiman CA, Zheng W. Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction. Nat Genet 56(5):819-826, 2024. e-Pub 2024. PMID: 38741014.
10. Smith-Graziani DJ, Parker PA, Peterson SK, Bedrosian I, Shen Y, Black DM, DeSnyder S, Hunt K, Dong W, Brewster AB. Prospective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer. Ann Surg 277(3):617-623, 2023. e-Pub 2023. PMID: 33938495.
11. Irajizad E, Wu R, Vykoukal J, Murage E, Spencer R, Dennison JB, Moulder S, Ravenberg E, Lim B, Litton J, Tripathym D, Valero V, Damodran S, Rauch GM, Adrada B, Candelaria R, White JB, Brewster A, Arun B, Long JP, Do KA, Hanash S, Fahrmann JF. Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Front Artif Intell 5, 2022. e-Pub 2022. PMID: 36034598.
12. Ligibel JA, Pierce LJ, Bender CM, Crane TE, Dieli-Conwright C, Hopkins JO, Master GA, Schenkel C, Garret-Mayer E, Katta S, Merrill JK, Salamone JM, Brewster AM. Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey. American Cancer Society 128(14):2817-2825, 2022. e-Pub 2022. PMID: 35442532.
13. Niemiro GM, Coletta AM, Agha NH, Mylabathula PL, Baker FL, Brewster AM, Bevers TB, Fuentes-Mattei E, Basen-Engquist K, Katsanis E, Gilchrist SC, Simpson RJ. Correction: Salutary effects of moderate but not high intensity aerobic exercise training on the frequency of peripheral T-cells associated with immunosenescence in older women at high risk of breast cancer: a randomized controlled trial. Immun Ageing 19(1):30, 2022. e-Pub 2022. PMID: 35676680.
14. Robertson MC, Cox-Martin E, Shegog R, Markham CM, Fujimoto K, Durand CP, Brewster A, Lyons EJ, Liao Y, Flores SA, Basen-Engquist KM. The Acceptability of an Electronically Delivered Acceptance- and Mindfulness-Based Physical Activity Intervention for Survivors of Breast Cancer: One-Group Pretest-Posttest Design. JMIR Cancer 8(2):e31815, 2022. e-Pub 2022. PMID: 35486425.
15. Niemiro GM, Coletta AM, Agha NH, Mylabathula PL, Baker FL, Brewster AM, Bevers TB, Fuentes-Mattei E, Basen-Engquist K, Katsanis E, Gilchrist SC, Simpson RJ. Salutary effects of moderate but not high intensity aerobic exercise training on the frequency of peripheral T-cells associated with immunosenescence in older women at high risk of breast cancer: a randomized controlled trial. Immun Ageing 19(1):17, 2022. e-Pub 2022. PMID: 35321743.
16. Schembre SM, Jospe MR, Bedrick EJ, Li L, Brewster AM, Levy E, Dirba DD, Campbell M, Taylor RW, Basen-Engquist KM. Hunger Training as a self-regulation strategy in a comprehensive weight loss program for breast cancer prevention: a randomized feasibility study. Cancer Prev Res (Phila) 15(3):193-201, 2022. e-Pub 2022. PMID: 34893531.
17. Robertson MC, Cox-Martin E, Liao Y, Flores SA, Shegog R, Markham CM, Fujimoto K, Durand CP, Brewster A, Lyons EJ, Basen-Engquist KM. Acceptance- and mindfulness-based techniques for physical activity promotion in breast cancer survivors: a qualitative study. Support Care Cancer 30(1):465-473, 2022. e-Pub 2022. PMID: 34313858.
18. Coletta AM, Agha NH, Baker FL, Niemiro GM, Mylabathula PL, Brewster AM, Bevers TB, Fuentes-Mattei E, Basen-Engquist K, Gilchrist SC, Simpson RJ. The Impact of High-Intensity Interval Exercise Training on NK-cell Function and Circulating Myokines for Breast Cancer Prevention among Women at High-Risk for Breast Cancer. Breast Cancer Res Treat 187(2):407-416, 2021. e-Pub 2021. PMID: 33555464.
19. Singareeka Raghavendra A, Alameddine HF, Andersen CR, Selber JC, Brewster AM, Barcenas CH, Caudle AS, Arun BK, Tripathy D, Ibrahim NK. Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer. Cancers (Basel) 13(9), 2021. e-Pub 2021. PMID: 33922702.
20. Ballhausen A, Wheler JJ, Karp DD, Piha-Paul SA, Fu S, Pant S, Tsimberidou AM, Hong DS, Subbiah V, Holley VR, Huang HJ, Brewster AM, Koenig KB, Ibrahim NK, Meric-Bernstam F, Janku F. Phase I study of everolimus, letrozole, and trastuzumab in patients with hormone receptor-positive metastatic breast cancer or other solid tumors. Clin Cancer Res 27(5):1247-1255, 2021. e-Pub 2021. PMID: 33115815.
21. Basen-Engquist KM, Raber M, Carmack CL, Arun B, Brewster AM, Fingeret M, Schembre SM, Harrison C, Perkins HY, Li Y, Song J, Chen M, Murray JL. Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study. Support Care Cancer 28(12):5821-5832, 2020. e-Pub 2020. PMID: 32249355.
22. D'Agostino TA, Brewster AM, Peterson SK, Bedrosian I, Parker PA. Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis. Transl Behav Med 10(2):347-354, 2020. e-Pub 2020. PMID: 30561744.
23. Litton JK, Scoggins ME, Hess KR, Adrada BE, Murthy RK, Damodaran S, DeSnyder SM, Brewster AM, Barcenas CH, Valero V, Whitman GJ, Schwartz-Gomez J, Mittendorf EA, Thompson AM, Helgason T, Ibrahim N, Piwnica-Worms H, Moulder SL, Arun BK. Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol 38(5):JCO1901304, 2020. e-Pub 2020. PMID: 31461380.
24. Visvanathan K, Fabian CJ, Bantug E, Brewster AM, Davidson NE, DeCensi A, Floyd JD, Garber JE, Hofstatter EW, Khan SA, Katapodi MC, Pruthi S, Raab R, Runowicz CD, Somerfield MR. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. J Clin Oncol 37(33):JCO1901472, 2019. e-Pub 2019. PMID: 31479306.
25. Coletta AM, Brewster AM, Chen M, Li Y, Bevers TB, Basen-Engquist K, Gilchrist SC. High-Intensity Interval Training is Feasible in Women at High Risk for Breast Cancer. Med Sci Sports Exerc 51(11):2193-2200, 2019. e-Pub 2019. PMID: 31269007.
26. Lim B, Murthy RK, Lee J, Jackson SA, Iwase T, Davis DW, Willey JS, Wu J, Shen Y, Tripathy D, Alvarez R, Ibrahim NK, Brewster AM, Barcenas CH, Brown PH, Giordano SH, Moulder SL, Booser DJ, Moscow JA, Piekarz R, Valero V, Ueno NT. A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment. Br J Cancer 120(12):1105-1112, 2019. e-Pub 2019. PMID: 31097774.
27. Ligibel JA, Jones LW, Brewster AM, Clinton SK, Korde LA, Oeffinger KC, Bender CM, Tan W, Merrill JK, Katta S, Alfano CM. Oncologists' Attitudes and Practice of Addressing Diet, Physical Activity, and Weight Management With Patients With Cancer: Findings of an ASCO Survey of the Oncology Workforce. J Oncol Pract 15(6):e520-e528, 2019. e-Pub 2019. PMID: 31095436.
28. Bedrosian I, Parker PA, Brewster AM. Who should get a contralateral prophylactic mastectomy for breast cancer?. Cancer 125(9):1400-1403, 2019. e-Pub 2019. PMID: 30645775.
29. Thomas PS, Class CA, Gandhi TR, Bambhroliya A, Do KA, Brewster AM. Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas. Cancer Causes Control 30(4):409-415, 2019. e-Pub 2019. PMID: 30868330.
30. Coletta AM, Marquez G, Thomas P, Thoman W, Bevers T, Brewster AM, Hawk E, Basen-Engquist K, Gilchrist SC. Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors. PLoS One 14(8):e0220814, 2019. e-Pub 2019. PMID: 31369653.
31. Yam C, Murthy RK, Rauch GM, Murray JL, Walters RS, Valero V, Brewster AM, Bast RC, Booser DJ, Giordano SH, Esteva FJ, Yang W, Hortobagyi GN, Moulder SL, Arun B. A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β. Invest New Drugs 36(6):1103-1109, 2018. e-Pub 2018. PMID: 30311036.
32. Advani P, Bondy M, Thompson PA, Martínez ME, Nodora JN, Vernon SW, Diamond P, Burnett J, Brewster AM. Impact of Acculturation on Breast Cancer Treatment and Survivorship Care among Mexican American Patients in Texas. J Cancer Surviv 12(5):659-668, 2018. e-Pub 2018. PMID: 30043339.
33. Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM. Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol 36(25):JCO2018786442, 2018. e-Pub 2018. PMID: 30044695.
34. Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez RH, Willey JS, Parker CA, Song J, Shen Y, Hu J, Wu W, Li N, Babiera GV, Murray JL, Arun BK, Brewster AM, Reuben JM, Stauder MC, Barnett CM, Woodward WA, Le-Petross HTC, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncol 4(9):1207-1213, 2018. e-Pub 2018. PMID: 29879283.
35. Reddy JP, Atkinson RL, Larson R, Burks JK, Smith D, Debeb BG, Ruffell B, Creighton CJ, Bambhroliya A, Reuben JM, Van Laere SJ, Krishnamurthy S, Symmans WF, Brewster AM, Woodward WA. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Res Treat 171(2):283-293, 2018. e-Pub 2018. PMID: 29858753.
36. Brewster AM, Thomas P, Brown P, Coyne R, Yan Y, Checka C, Middleton L, Do KA, Bevers T. A system-level approach to improve the uptake of anti-estrogen preventive therapy among women with atypical hyperplasia and lobular cancer in situ. Cancer Prev Res (Phila) 11(5):295-302, 2018. e-Pub 2018. PMID: 29618460.
37. LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ. Alcohol and Cancer: A Statement of the American Society of Clinical Oncology. J Clin Oncol 36(1):83-93, 2018. e-Pub 2018. PMID: 29112463.
38. Pande M, Joon A, Brewster AM, Chen WV, Hopper JL, Eng C, Shete S, Casey G, Schumacher F, Lin Y, Harrison TA, White E, Ahsan H, Andrulis IL, Whittemore AS, John EM, Ko Win A, Makalic E, Schmidt DF, Kapuscinski MK, Ochs-Balcom HM, Gallinger S, Jenkins MA, Newcomb PA, Lindor NM, Peters U, Amos CI, Lynch PM. Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One 13(4):e0196245, 2018. e-Pub 2018. PMID: 29698419.
39. Berkman AM, Brewster AM, Jones LW, Yu J, Lee JJ, Peng SA, Crocker A, Ater JL, Gilchrist SC. Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer Survivors. J Adolesc Young Adult Oncol 6(3):414-421, 2017. e-Pub 2017. PMID: 28530506.
40. Advani P, Brewster AM, Baum GP, Schover LR. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy. J Cancer Surviv 11(4):477-485, 2017. e-Pub 2017. PMID: 28229275.
41. Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden And Breast Cancer Subtype. J Clin Oncol 35(10):JCO2015631010, 2017. e-Pub 2017. PMID: 28135148.
42. Stecklein SR, Reddy JP, Wolfe AR, Lopez MS, Fouad TM, Debeb BG, Ueno NT, Brewster AM, Woodward WA. Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival. J Cancer 8(10):1726-1732, 2017. e-Pub 2017. PMID: 28819368.
43. Mitri Z, Nanda R, Blackwell K, Costelloe CM, Hood I, Wei C, Brewster AM, Ibrahim NK, Koenig KB, Hortobagyi GN, Van Poznak C, Rimawi MF, Moulder-Thompson S, Research Consortium TBC. TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis. Clin Cancer Res 22(23):5706-5712, 2016. e-Pub 2016. PMID: 27166393.
44. Davies KR, Brewster AM, Bedrosian I, Parker PA, Crosby MA, Peterson SK, Shen Y, Volk RJ, Cantor SB. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033). Breast Cancer Res 18(1):93, 2016. e-Pub 2016. PMID: 27650678.
45. Atkinson RL, El-Zein R, Valero V, Lucci A, Bevers TB, Fouad T, Liao W, Ueno NT, Woodward WA, Brewster AM. Epidemiological Risk Factors Associated with Inflammatory Breast Cancer Subtypes. Cancer Causes and Control 27(3):359-66, 2016. e-Pub 2016. PMID: 26797453.
46. Parker PA, Peterson SK, Bedrosian I, Crosby MA, Shen Y, Black DM, Babiera G, Kuerer HM, Ying J, Dong W, Cantor SB, Brewster AM. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer. Ann Surg 263(1):178-183, 2016. e-Pub 2016. PMID: 25822675.
47. Nodora JN, Cooper R, Talavera GA, Gallo L, Meza Montenegro MM, Komenaka I, Natarajan L, Gutiérrez Millán LE, Daneri-Navarro A, Bondy M, Brewster A, Thompson P, Martinez ME. Acculturation, Behavioral Factors, and Family History of Breast Cancer among Mexican and Mexican-American Women. Womens Health Issues 25(5):494-500, 2015. e-Pub 2015. PMID: 26189937.
48. Wolfe AR, Atkinson RL, Reddy JP, Debeb BG, Larson R, Li L, Masuda H, Brewer T, Atkinson BJ, Brewster A, Ueno NT, Woodward WA. High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer. Int J Radiat Oncol Biol Phys 91(5):1072-80, 2015. e-Pub 2015. PMID: 25832697.
49. Guan X, Liu H, Ju J, Li Y, Li P, Wang LE, Brewster AM, Buchholz TA, Arun BK, Wei Q, Liu Z. Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged 55 years. Mol Carcinog 54(4):281-90, 2015. e-Pub 2015. PMID: 24166930.
50. Kogawa T, Fouad TM, Wei C, Masuda H, Kai K, Fujii T, El-Zein R, Chavez-MacGregor M, Litton JK, Brewster A, Alvarez RH, Hortobagyi GN, Valero V, Theriault R, Ueno NT. Association of body mass index changes during neoadjuvant chemotherapy with pathologic complete response and clinical outcomes in patients with locally advanced breast cancer. J Cancer 6(4):310-318, 2015. e-Pub 2015. PMID: 25767600.
51. Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-Bertrandt A. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med 11(12):3102-11, 2014. e-Pub 2014. PMID: 25141792.
52. Brewster AM, Chavez-MacGregor M, Brown P. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lancet Oncol 15(13):e625 - e634, 2014. e-Pub 2014. PMID: 25456381.
53. Deshmukh AA, Cantor SB, Crosby MA, Dong W, Shen Y, Bedrosian I, Peterson SK, Parker PA, Brewster AM. Cost of contralateral prophylactic mastectomy. Ann Surg Oncol 21(9):2823-30, 2014. e-Pub 2014. PMID: 24809301.
54. Pande M, Bondy ML, Do KA, Sahin AA, Ying J, Mills GB, Thompson PA, Brewster AM. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival. Breast Cancer Res Treat 147(2):381-7, 2014. e-Pub 2014. PMID: 25108739.
55. Nodora JN, Gallo L, Cooper R, Wertheim BC, Natarajan L, Thompson PA, Komenaka IK, Brewster A, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Martínez ME. Reproductive and hormonal risk profile according to language acculturation and country of residence in the Ella Binational Breast Cancer Study. J Womens Health (Larchmt) 23(6):532-40, 2014. e-Pub 2014. PMID: 24475760.
56. Thompson PA, Ljuslinder I, Tsavachidis S, Brewster A, Sahin A, Hedman H, Henriksson R, Bondy ML, Melin BS. Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer. Cancer Res 74(11):2928-35, 2014. e-Pub 2014. PMID: 24879564.
57. Gonzalez-Angulo AM, Akcakanat A, Liu S, Green MC, Murray JL, Chen H, Palla SL, Koenig KB, Brewster AM, Valero V, Ibrahim NK, Moulder-Thompson S, Litton JK, Tarco E, Moore J, Flores P, Crawford D, Dryden MJ, Symmans WF, Sahin A, Giordano SH, Pusztai L, Do KA, Mills GB, Hortobagyi GN, Meric-Bernstam F. Open label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC vs. the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer. Ann Oncol 25(6):1122-7, 2014. e-Pub 2014. PMID: 24669015.
58. Advani PS, Ying J, Theriault R, Melhem-Bertrand A, Moulder S, Bedrosian I, Tereffe W, Black S, Pini TM, Brewster AM. Ethnic disparities in adherence to breast cancer survivorship surveillance care. Cancer 120(6):894-900, 2014. e-Pub 2014. PMID: 24258799.
59. Liu Y, Zhou R, Baumbusch LO, Tsavachidis S, Brewster AM, Do KA, Sahin A, Hortobagyi GN, Taube JH, Mani SA, Aarøe J, Wärnberg F, Børresen-Dale AL, Mills GB, Thompson PA, Bondy ML. Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer. Breast Cancer Res Treat 143(1):189-201, 2014. e-Pub 2014. PMID: 24305980.
60. Anderson K, Thompson PA, Wertheim BC, Martin L, Komenaka IK, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Madlensky L, Tobias M, Natarajan L, Martínez ME. Family history of breast and ovarian cancer and triple negative subtype in hispanic / Latina women. Springerplus 3(1):727, 2014. e-Pub 2014. PMID: 25713754.
61. Martinez ME, Wertheim BC, Natarajan L, Schwab R, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Komenaka IK, Thompson PA. Reproductive factors, heterogeneity and breast tumor subtypes in women of mexican descent. Cancer Epidemiol Biomarkers Prev 22(10):1853-61, 2013. e-Pub 2013. PMID: 23950213.
62. Atkinson RL, Yang WT, Rosen DG, Landis MD, Wong H, Lewis MT, Creighton CJ, Sexton KR, Hilsenbeck SG, Sahin AA, Brewster AM, Woodward WA, Chang JC. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency. Breast Cancer Res 15(5):R77, 2013. e-Pub 2013. PMID: 24008095.
63. Gonzalez-Angulo AM, Akcakanat A, Liu S, Green MC, Murray JL, Chen H, Palla SL, Koenig KB, Brewster AM, Valero V, Ibrahim NK, Moulder-Thompson S, Litton JK, Tarco E, Moore J, Flores P, Crawford D, Dryden MJ, Symmans WF, Sahin A, Giordano SH, Pusztai L, Do KA, Mills GB, Hortobagyi GN, Meric-Bernstam F. An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer. Oncologist 18(6):661-6, 2013. e-Pub 2013. PMID: 23697602.
64. Martínez ME, Pond E, Wertheim BC, Nodora JN, Jacobs ET, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Komenaka IK, Thompson P. Association between parity and obesity in Mexican and Mexican-American women: findings from the Ella Binational breast cancer study. J Immigr Minor Health 15(2):234-243, 2013. e-Pub 2013. PMID: 22618357.
65. Murray JL, Thompson P, Yoo SY, Do KA, Pande M, Zhou R, Liu Y, Sahin AA, Bondy ML, Brewster AM. Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer. Breast Cancer Res Treat 138(3):917-924, 2013. e-Pub 2013. PMID: 23529385.
66. Pande M, Thompson PA, Do KA, Sahin AA, Amos CI, Frazier ML, Bondy ML, Brewster AM. Genetic variants in the vitamin D pathway and breast cancer disease-free survival. Carcinogenesis 34(3):587-94, 2013. e-Pub 2013. PMID: 23180655.
67. Bidstrup PE, Dalton SO, Christensen J, Tjonneland A, Larsen SB, Karlsen R, Brewster A, Bondy M, Johansen C. Changes in body mass index and alcohol and tobacco consumption among breast cancer survivors and cancer-free women: a prospective study in the Danish Diet, Cancer and Health Cohort. Acta Oncol 52(2):327-35, 2013. e-Pub 2013. PMID: 23244678.
68. Cruz GI, Martínez ME, Natarajan L, Wertheim BC, Gago-Dominguez M, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Schedin P, Komenaka IK, Castelao JE, Carracedo A, Redondo CM, Thompson PA. Hypothesized role of pregnancy hormones on HER2+ breast tumor development. Breast Cancer Res Treat 137(1):237-46, 2013. e-Pub 2013. PMID: 23135573.
69. Bailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast. Cancer 119(1):150-7, 2013. e-Pub 2013. PMID: 22736444.
70. Bayraktar S, Thompson PA, Yoo SY, Do KA, Sahin AA, Arun BK, Bondy ML, Brewster AM. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. Oncologist 18(5):493-500, 2013. e-Pub 2013. PMID: 23635555.
71. Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 118(22):5637-43, 2012. e-Pub 2012. PMID: 22517269.
72. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-1141, 2012. e-Pub 2012. PMID: 22392043.
73. Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer 118(9):2378-84, 2012. e-Pub 2012. PMID: 22006179.
74. Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14(3):R82, 2012. e-Pub 2012. PMID: 22621306.
75. Wang LE, Han CH, Xiong P, Bondy ML, Yu TK, Brewster AM, Shete S, Arun BK, Buchholz TA, Wei Q. Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study. Breast Cancer Res Treat 132(3):1147-55, 2012. e-Pub 2012. PMID: 22218884.
76. Kelly CM, Green MC, Broglio K, Thomas ES, Brewster AM, Valero V, Ibrahim NK, Gonzalez-Angulo AM, Booser DJ, Walters RS, Hunt KK, Hortobagyi GN, Buzdar AU. Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. J Clin Oncol 30(9):930-5, 2012. e-Pub 2012. PMID: 22331946.
77. Arun BK, Valero V, Liu D, Brewster AM, Green M, Gutierrez-Barrera AM, Akar U, Rivera E, Esteva FJ, Buzdar AU, Hortobagyi GN, Sneige N. Short-term biomarker modulation prevention study of Anastrozole in Women at increased risk for second primary breast cancer. Cancer Prev Res (Phila) 5(2):276-82, 2012. e-Pub 2012. PMID: 22102688.
78. Garcia RZ, Carvajal SC, Wilkinson AV, Thompson PA, Nodora JN, Komenaka IK, Brewster A, Cruz GI, Wertheim BC, Bondy ML, Martinez ME. Factors that influence mammography use and breast cancer. Cancer Causes Control 23(1):165-73, 2012. e-Pub 2012. PMID: 22080276.
79. Del Fabbro E, Parsons H, Warneke CL, Pulivarthi K, Litton JK, Dev R, Palla SL, Brewster A, Bruera E. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist 17(10):1240-5, 2012. e-Pub 2012. PMID: 22903527.
80. Brewster AM, Etzel C, Zhou R, Wong Y, Edge S, Blayney DW, Wilson J, Hudis C, Ottesen R, Hughes ME, Weeks JC, Theriault RL. The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. Breast Cancer Res Treat 130(3):897-904, 2011. e-Pub 2011. PMID: 21809116.
81. Brewster AM, Thompson P, Sahin AA, Do K, Edgerton M, Murray JL, Tsavachidis S, Zhou R, Liu Y, Zhang L, Mills G, Bondy M. Copy number imbalances between screen and symptom-detected breast cancers and impact on disease-free survival. Cancer Prev Res (Phila) 4(10):1609-16, 2011. e-Pub 2011. PMID: 21795423.
82. Zhang G, Brewster A, Guan B, Fan Z, Brown PH, Xu XC. Tumor-suppressor activity of RRIG1 in breast cancer. BMC Cancer 11:32, 2011. e-Pub 2011. PMID: 21266059.
83. Thompson PA, Brewster AM, Kim-Anh D, Baladandayuthapani V, Broom BM, Edgerton ME, Hahn KM, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy ML. Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLos ONE. PLoS One 6(8):e23543, 2011. e-Pub 2011. PMID: 21858162.
84. Brewster AM, Patterson SL, Forman MR, Hughes-Halbert C, Limburg PJ, Ondrey FG, Paskett ED, Wetter DW, Hawk ET. Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research. Cancer Prev Res (Phila) 3(8):1044-8, 2010. e-Pub 2010. PMID: 20663980.
85. Han CH, Lu J, Wei Q, Bondy ML, Brewster AM, Yu TK, Buchholz TA, Arun BK, Wang LE. The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat 122(1):243-9, 2010. e-Pub 2010. PMID: 20033770.
86. Brown PH, Viner JL, Brewster A, Heckman CJ, Hursting S, Johnson K, Mao JT. Conference Report: Seventh Annual AACR International Conference on Frontiers in Cancer Prevention Research. Cancer Prev Res (Phila) 2(11):995-8, 2009. e-Pub 2009. PMID: 19892666.
87. Moulder SL, Symmans WF, Booser DJ, Madden TL, Lipsanen C, Yuan L, Brewster AM, Cristofanilli M, Hunt KK, Buchholz TA, Zwiebel J, Valero V, Hortobagyi GN, Esteva FJ. Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer. Clin Cancer Res 14(23):7909-16, 2008. e-Pub 2008. PMID: 19047121.
88. Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26(25):4072-7, 2008. e-Pub 2008. PMID: 18757321.
89. Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100(16):1179-83, 2008. e-Pub 2008. PMID: 18695137.
90. Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LE. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged
91. Rivera E, Mejia JA, Arun BK, Adinin RB, Walters RS, Brewster A, Broglio KR, Yin G, Esmaeli B, Hortobagyi GN, Valero V. Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer. Cancer 112(7):1455-61, 2008. e-Pub 2008. PMID: 18300256.
92. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res 13(21):6532-9, 2007. e-Pub 2007. PMID: 17975167.
93. Brewster AM, Do KA, Thompson PA, Hahn KM, Sahin AA, Cao Y, Stewart MM, Murray JL, Hortobagyi GN, Bondy ML. Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol 25(28):4438-44, 2007. e-Pub 2007. PMID: 17785707.
94. Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gong Y, Browne D, Hortobagyi GN, Sneige N. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 13(16):4943-8, 2007. e-Pub 2007. PMID: 17699874.
95. Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 25(15):1974-8, 2007. e-Pub 2007. PMID: 17513803.
96. Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation. Cancer Epidemiol Biomarkers Prev 16(5):950-5, 2007. e-Pub 2007. PMID: 17507621.
97. Johnson CM, Ensor J, Broglio K, Smolenski D, Ravdin P, Amos C, Meric-Bernstam F, Brewster A, Bevers T, Arun B, Berry D. Building a predictive breast cancer risk model. AMIA Annu Symp Proc:995, 2007. e-Pub 2007. PMID: 18694095.
98. Lu J, Wei Q, Bondy ML, Yu TK, Li D, Brewster A, Shete S, Sahin A, Meric-Bernstam F, Wang LE. Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 107(9):2245-53, 2006. e-Pub 2006. PMID: 17063466.
99. Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LE. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women
100. Brewster AM, Jorgensen TJ, Ruczinski I, Huang HY, Hoffman S, Thuita L, Newschaffer C, Lunn RM, Bell D, Helzlsouer KJ. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat 95(1):73-80, 2006. e-Pub 2006. PMID: 16319991.
101. Brewster AM, Christo DK, Lai H, Helzlsouer K. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits. Cancer 103(6):1147-53, 2005. e-Pub 2005. PMID: 15674856.
102. Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25(9):1695-700, 2004. e-Pub 2004. PMID: 15090466.
103. Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13(8):1271-5, 2004. e-Pub 2004. PMID: 15298945.
104. Brewster A. A student's view of a medical teaching exercise. N Engl J Med 329(26):1971-2, 1993. e-Pub 1993. PMID: 8247071.

Review Articles

1. Ahmed T, Mouhayar E, Banchs J, Karimzad K, Hassan SA, Brewster A, Yusuf SW. Extensive Painless Aortic Dissection in a Patient With Breast Cancer. Curr Probl Cardiol 48(8):101253, 2023. e-Pub 2023. PMID: 35577080.
2. Advani P, Advani S, Nayak P, VonVille HM, Diamond P, Burnett J, Brewster AM, Vernon SW. Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review. J Cancer Surviv 16(3):514-530, 2022. e-Pub 2022. PMID: 33982233.
3. Gapstur SM, Bandera EV, Jernigan DH, LoConte NK, Southwell BG, Vasiliou V, Brewster AM, Naimi TS, Scherr CL, Shield KD. Alcohol and Cancer: Existing Knowledge and Evidence Gaps Across the Cancer Continuum. Cancer Epidemiol Biomarkers Prev 31(1):5-10, 2022. e-Pub 2022. PMID: 34728469.
4. Yin, AB, Brewster, A, Barac, A, Thoman, W, Oeffinger, KC, Gilchrist, SC. Cardiovascular Prevention Strategies in Breast Cancer. JACC: CardioOncology 1(2):322-325, 2019. e-Pub 2019. PMID: 34396201.
5. Bambhroliya A, Chavez-MacGregor M, Brewster AM. Barriers to the Use of Breast Cancer Risk Reduction Therapies. J Natl Compr Canc Netw 13(7):927-35, 2015. e-Pub 2015. PMID: 26150584.
6. Davies KR, Cantor SB, Brewster AM. Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy. Int J Womens Health 7:181-187, 2015. e-Pub 2015. PMID: 25678823.
7. Satcher RL, Bogler O, Hyle L, Lee A, Simmons A, Williams R, Hawk E, Matin S, Brewster AM. Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center. J Surg Oncol 110(4):353-9, 2014. e-Pub 2014. PMID: 24889208.
8. Sexton KR, Franzini L, Day RS, Brewster A, Vernon SW, Bondy ML. A review of body size and breast cancer risk in Hispanic and African American women. Cancer 117(23):5271-81, 2011. e-Pub 2011. PMID: 21598244.
9. Brewster AM, Parker PA. Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer. Oncologist 16(7):935-41, 2011. e-Pub 2011. PMID: 21672945.
10. Martínez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What can we learn about disease etiology from case-case analyses? Lessons from breast cancer. Cancer Epidemiol Biomarkers Prev 19(11):2710-4, 2010. e-Pub 2010. PMID: 20870734.
11. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 27(2):279-88, 2009. e-Pub 2009. PMID: 19064970.
12. Brewster A, Helzlsouer K. Breast cancer epidemiology, prevention, and early detection. Curr Opin Oncol 13(6):420-5, 2001. e-Pub 2001. PMID: 11673680.

Professional Educational Materials

1. Brewster AM. Male Breast Cancer Part 2, 2002.
2. Brewster AM. Male Breast Cancer Part 1, 2001.
3. Brewster AM. Does Oral Contraceptive Use Increase the Risk of Breast Cancer?, 2001.

Other Articles

1. Brewster, A, Mcgaha, R Breast Cancer Recurrence in Older Women Five to Ten Years after Diagnosis. Breast Diseases 21(4):320-321, 2010.

Abstracts

1. Schembre S, Basen-Engquist K, Jospe M, Taylor R, Brewster A, Liang L. Feasibility and impact of adding Hunger Training to an evidence-based weight loss intervention: a pilot study. Research Talk at the Society of Behavioral Medicine's 2021 Annual Meeting & Scientific Sessions, 2021. e-Pub 2021.
2. Smith-Graziani D, Parker PA, K Peterson PS, Bedrosian I, Shen Y, Black DM, DeSnyder SM, Hunt KK, Dong W, Brewster AM. Prospective Study of Pain outcomes Associated with Contralateral Prophylactic Mastectomy in Women with Nonhereditary Breast Cancer Center. 2019 Annual Meeting of the American Society of Clinical Oncology, 2019. e-Pub 2019.
3. PA Thompson PA, Brewster AM, S Tsavachidis S, G Armstrong G, Do K, MF Ha MF, C Gutierrez C, F, Symmans, M Bondy M. Cumulative copy number imbalances after neoadjuvant chemotherapy residual breast tumor is an independent predictor of relapse. San Antonio Breast Cancer Symposium, 2018. e-Pub 2018.
4. Brewster AM, S Cantor S, K Davies K, I Bedrosian I, P Parker P, S Garrison S, RJ Volk RJ. Field testing of a Point-of-care Decision Support tool for Contralateral Prophylactic Mastectomy. San Antonio Breast Cancer Symposium, 2018. e-Pub 2018.
5. Brewster AM, Peterson S, Bedrosian I, Thompson A, Black S, Nelson J, Cook R, DeSnyder S, Hunt K, Cantor SB, Volk RJ, Wenli S, Shen U, Parker PA. Prospective Assessment of Psychosocial Factors Associated with Contralateral Prophylactic Mastectomy. 2017 Annual Meeting of the American Society of Clinical Oncology, 2017. e-Pub 2017.
6. Brewster AM, Peterson S, Bedrosian I, Dong W, Cantor S, Volk R, Dupont H, Shen Y, Parker P. Psychosocial predictors of decision making for contralateral prophylactic mastectomy. 2016 Annual Meeting of the American Society of Clinical Oncology, 2016. e-Pub 2016.
7. Davies KR, Brewster AM, Parker PA, Bedrosian I, Crosby M, Peterson S, Shen Y, Volk RJ, Cantor SB. Outcomes of Contralateral Prophylactic Mastectomy in Relation to Familial History: A Decision Analysis. 2016 Annual Meeting of the American Association of Cancer Research, 2016. e-Pub 2016.
8. Basen-Engquist K, Murray JL, Brewster A, Schembre S, Song J, Gutierrez AM, Arun B. Randomized pilot study of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy. AACR Frontiers in Cancer Prevention meeting, 2014, 2014. e-Pub 2014.
9. Atkinson RL, Symmans W, Bevers TB, Woodward WA, Brewster AM. Prevalence of breast stem cells in high-risk benign breast lesions and association with breastfeeding. AACR Annual Meeting, 2014, 2014. e-Pub 2014.
10. Pande M, Bondy ML, Do KA, Sahin AA, Ying J, Mills GB, Thompson PA, Brewster AM. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival. AACR Annual Meeting, 2014, 2014. e-Pub 2014.
11. Gole P, Ying J, heriault R, Melhem-Bertrand A, Moulder S, Bedrosian I, Tereffe W, Black S, McNeil L, Giordano S, Pini M, Brewster AM. Ethnic disparities in adherence to breast cancer survivorship care. ASCO Breast Cancer Symposium 120(6):894-900, 2013. e-Pub 2013.
12. Atkinson RL, El-Zien R, Fouad T, Bondy M, Ueno NT, Woodward WA, Brewster A. Epidemiological risk factors associated with the inflammatory breast cancer subtypes. San Antonio Breast Symposium, 2013. e-Pub 2013.
13. Nimmons S, Bambhroliya A, Bevers T, Ying J, Brown P, Cook E, Newman L, Brewster A. The evaluation of breast cancer chemoprevention uptake in a high-risk cohort. AACR Frontiers of Cancer Prevention Meeting, 2013. e-Pub 2013.
14. Brewster AM, Bondy M, Do K, Sahin A, Hale K, Wei C, Mills G, Thompson P. The association between germline genetic variants in the P13K mutations in breast tumors. AACR Frontiers of Cancer Prevention Meeting, 2012. e-Pub 2012.
15. Bayraktar, S, Thompson, PA, Yoo, SY, Do, K, Sahin, AA, Arun, BK, Bondy, ML, Brewster, AM. Prognostic relevance of eight genome wide association studies-identified single-nucleotide polymorphisms in primary breast cancer. AACR Frontiers of Cancer Prevention Meeting, 2011. e-Pub 2011.
16. Brewster, AM, Parker, P, Bedrosian, I, Dong, W, Peterson, S, Cantor, S, Crosby, M, Shen, Y. The association between contralateral prophylactic mastectomy and breast cancer survival outcomes. ASCO Meeting, 2011. e-Pub 2011.
17. Murray, JL, Thompson, P, Zhou, R, Yoo, SY, Liu, Y, Do, K, Sahin, A, Bondy, M, Brewster AM. Prognostic value of single nucleotide polymorphisms (SNPs) of candidate genes associated with inflammation in early stage breast cancer. ASCO Meeting, 2011. e-Pub 2011.
18. Murray JL, Thompson P, Tuna M, Brewster AM, Do K, Edgerton ME, Sahin A, Mills GB, Tsachavdis S, Bondy M. Association of gene copy number alterations in formalin-fixed, paraffin-embedded tumors with prognostic molecular and pathologic tumor subtypes in early-stage breast cancer. ASCO Meeting Abstracts, 2010. e-Pub 2010.
19. Brewster AM, Thompson P, Do KA, a S, Zhang L, Murray JL, Tsachavidis S, Mills GB, Bondy M. Investigation of ethnic differences in the prevalence of chromosomal number aberrations of luminal and triple-negative breast cancers associated with risk of recurrence. ASCO Meeting Abstracts, 2010. e-Pub 2010.
20. Bambhroliya A, Bondy M, Thompson P, Sahin A, Murray JL, Zhou R, Sexton K, Brewster AM. Epidemiologic risk factors associated with breast cancer subtypes. ASCO Meetiing Abstracts, 2010. e-Pub 2010.
21. Thompson P, Do K, Brewster AM, Shim J, Murray JL, Tsachavidis S, Sahin A, Mills GB, Bondy M. Integration of specific copy number imbalances and prediction models of early-stage breast cancer recurrence. ASCO Meeting Abstracts, 2010. e-Pub 2010.
22. Brewster AM, Martinez E, Thompson P, Zhou R, Stewart M, Sahin A, Edgerton M, and Bondy M. The relationship between physical activity, obesity and breast cancer characteristics among Mexican American and African American women. Second American Association for Cancer Research, The Science of Cancer Health Disparities Conference; 2009. February 3-6; Carefree, AZ. Philadelphia (PA): AACR; 2009, Abstract No. B44, 2009. e-Pub 2009.
23. Dominici LS, Mittendorf EA, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera G, Meric-Bernstam F, Yu TK, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy, 2009. e-Pub 2009.
24. R Zenuk R, P Thompson P, J, Nodora, GCruz, A Brewster A, Bondy M, M Stewart M Edgerton M, A Sahin A, J Murray J, ME Martinez ME. Breast cancer detection and screening mammography in Mexican American women: Findings from the Ella Binational Breast Cancer Study, 2009. e-Pub 2009.
25. Brewster A M, Etzel C, Zhou R, Wong Y, Edge S B, Blayney D W, Wilson J, Hudis C, Weeks J C, Theriault R L. The impact of obesity on adherence to the National Comprehensive Cancer Network (NCCN) guidelines recommending chemotherapy for patients with operable breast cancer, 2009. e-Pub 2009.
26. Meza MM, Martinez ME, Thompson P, Komenaka I, Gutierrez LE, Bondy M, Brewster AM, Edgerton M, Hortobagyi G, Sahin A, Daneri A, Jimenez M, Aramburo I, Caire G, Ortiz M, Perez L, Salazar O, Chavez M, Ornelas J, Gomez A, Morgan G, Vazquez G, Flores MR, Castro JM. The Ella Binational Breast Cancer Study: Risk factor and tumor marker profile in women of Mexican ancestry. Second American Association for Cancer Research, The Science of Cancer Health Disparities Conference, 2009. e-Pub 2009.
27. Brewster AM, Thompson PA, Cao Y, James LM, Stewart MM, Berry DA, Bondy ML. Method of detection is a prognostic factor for outcome among women diagnosed with early stage breast cancer. San Antonio Breast Cancer Symposium. Abstract No. 551824, 2008. e-Pub 2008.
28. Brewster AM, Hortobagyi GN, Broglio KR, S-W K, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. In: Proceedings of the 99th Annual Meeting of the American Association for Cancer Research; 2008 Apr 12-16; San Diego, CA. Philadelphia (PA): AACR; 2008. Abstract No. 3031, 2008. e-Pub 2008.
29. Brewster AM, Gorlov I, Yang W, Wang L, Bondy M, Carkaci S, Armstrong G, Pugh T, DeFreese D, Gramling B, Manjeshwar S, Shimasaki C, Jupe E. Epidemiological and genetic determinants of mammographic density. In: Proceedings of the Sixth AACR Interanational Conference on Frontiers in Cancer Prevention Research; 2007 Dec 5-8; Phliadelphia, PA, Philadelphia (PA): AACR; 2007. Abstract nr B104, 2007. e-Pub 2007.
30. Johnson CM, Ensor J, Broglio KR, Smolenski D, Ravdin P, Amos C, Meric-Bernstam, Brewster A, Bevers T, Arun B, Berry D. Building a predictive breast cancer risk model. AMIA Annual Symp Proc. Abstract No. M-105, 2007. e-Pub 2007.
31. Brewster AM, Do K, Thompson PA, Hahn KM, Sahin AA, Cao Y, Stewart MM, Murray JL, Hortobagyi GN and Bondy ML. Epidemiological risk factors for breast cancer recurrence according to estrogen and progesterone receptor status. In: Proceedings of the 98th Annual Meeting of the American Association for Cancer Research; 2007 Apr 14-18; Los Angeles, CA. Philadelphia (PA): AACR; 2007. Abstract nr 2609, 2007. e-Pub 2007.
32. Litton JK, Gonzalez-Angulo AM, Warneke CL, Kau S, Buzdar AU, Bondy M, Mahabir AM, Hortobagyi GN, Brewster AM. The relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 531, 2007. e-Pub 2007.
33. Lu J, Wei Q, Bondy ML, Wang L, Li D, Brewster A, T-K Y, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, L-E W. Polymorphisms and haplotypes of the NBSI gene associated with risk of sporadic breast cancer in young women: A case-control study. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr 2040, 2006. e-Pub 2006.
34. Ruczinski I, Jorgensen TJ, Brewster AM, Helzlsouer KJ. Statistical inference in gene association studies of cancer risks with partially missing family history data. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr 5369, 2006. e-Pub 2006.
35. Brewster AM, Lee JJ, Clayman GL, Clifford JL, Necesito-Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. Phase III trial of adjuvant 13-cis-retinoic acid and interferon-alpha for patients with aggressive skin squamous cell carcinoma. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr 5659, 2006. e-Pub 2006.
36. Brewster AM, El-Zein R, Hajek R, Hernandez MS, Gor B, Jones LA. Low fat diet and oxidative damage. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr B13, 2006. e-Pub 2006.
37. Rivera E, Mejia JA, Arun A, Adinin R, Walters R, Brewster AM, Broglio K, Yin G, Esteva FG, Hortobagyi GN, Valero V. Phase III study of docetaxel weekly (DW) versus every 3 weeks (D) in patients with metastatic breast cancer: Final results. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 574, 2006. e-Pub 2006.
38. Visvanathan K, Santor D, Ali S, Brewster AM, Arnold A, Armstrong D, Helzlsouer K. The reliability of ductal lavage in women at high risk for breast cancer. Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005: 1001, 2005. e-Pub 2005.
39. Rivera E, Valero V, Francis D, Meyers C, Brewster AM, Groves M, Royce M, Esteva F, Soto E, Murray JL, Pusztai L, Hortobagyi GN. The University of Texas M. D. Anderson Cancer Center, Houston, TX. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. San Antonio Breast Cancer Symposium. Abstract No. 1079, 2004. e-Pub 2004.
40. Shi Q, L-E W, Bondy ML, Brewster A, Singletary E, Wei Q. DNA repair capacity for benzo[a]pyrene diol epoxide-induced adducts, common XPD polymorphisms, and breast cancer. In: Proceedings of the 95th Annual Meeting of the American Association for Cancer Research; 2004 Mar 27-31; Orlando, FL. Philadelphia (PA): AACR; 2004. Abstract nr 2891, 2004. e-Pub 2004.
41. Esteva FJ, Madden TL, Lammey J, Symmans WF, Booser DJ, Arun B, Rivera E, Brewster AM, Valero V, Hortobagyi GN. Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC). Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14 S (July 15 Supplement), 2004: 3117, 2004. e-Pub 2004.

Book Chapters

1. Barcenas CH, Brewster AM. Overview of Breast Cancer Survivorship Management Guidelines. In: Breast Cancer, MD Anderson Cancer Care Series, 2015.
2. Brewster AM, Davidson NE, McCaskill-Stevens W. Chemoprevention for Breast Cancer: Overcoming Barriers to Treatment. In: Am Soc Clin Oncol Educ Book. American Society of Clinical Oncology, 85-90, 2012.
3. Brewster, A, Hortobagyi, GN. Locally Advanced Breast Cancer. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. Fourth. Elsevier, 1189-1199, 2009.
4. Brewster, A, Davidson, NE, Rosenfeld, JA. Breast cancer screening. In: Handbook of Women's Health. Cambridge University Press, 215-220, 2009.
5. Brewster A and Bondy M. Clinical and Molecular Epidemiology of Breast Cancer. In: Molecular Oncology of Breast Cancer. Jones & Bartlett Publishers, 2005.
6. Brewster AM, Hortobagyi GN. Locally Advanced Breast Cancer. In: The Breast: Comprehensive Management of Benign and Malignant Disorders. Elsevier, 2003.
7. Brewster A and Davidson N. Breast cancer screening. In: Handbook of Women's Health. Cambridge University Press, 383-398, 2001.

Letters to the Editor

1. Litton, J, Brewster, A. To the editor. Journal of Clinical Oncology 27: 830-831, 2009.